Dame Kay Davies - OUMNH 150th Anniversary Lectures

TL;DR

Muscular dystrophy is a devastating disease with no cure, but recent advancements in gene therapy and exon skipping offer hope for treatment.

Transcript

this is a indeed a wonderful place and it's a great honor to give this lecture today I was lectured many a time on electrochemistry when I did my chemistry undergraduate course here and I'm very pleased to see a they painted the walls and be you've got some nice pictures up so it's a much more friendly environment than it used to be so over the nex... Read More

Key Insights

• ☺️ Duchenne Muscular Dystrophy primarily affects boys due to the absence of a compensatory gene on the X chromosome, making treatment and prevention challenging.
• 😨 Current treatment options for MD are limited to supportive care, but advancements in gene therapy, myostatin inhibitors, and exon skipping show promise for future therapies.
• 👻 Genetic testing and prenatal diagnosis have improved significantly, allowing for early detection and potential intervention.
• 🥹 The development of personalized treatments based on individual genetic profiles holds promise for more effective therapies.
• 💪 Stem cell therapy has shown potential in regenerating muscle tissue, but more research is needed to overcome challenges in distributing stem cells throughout the body.

Questions & Answers

Q: What is the cause of Duchenne Muscular Dystrophy (DMD)?

DMD is caused by a mutation in the dystrophin gene, which leads to the absence or insufficient production of the dystrophin protein, resulting in muscle weakness and degeneration.

Q: Can MD be detected prenatally?

Yes, prenatal diagnosis for MD is possible through enzymatic analysis or DNA testing. However, there are ethical considerations regarding informing parents of a future diagnosis with a currently incurable disease.

Q: What is exon skipping?

Exon skipping is a technique where certain sections (exons) of the dystrophin gene are intentionally skipped during the protein production process. This can help produce a partially functional dystrophin protein.

Q: Are there any potential therapies for treating MD?

Several potential therapies are being explored, including myostatin inhibitors to increase muscle size, viral gene therapy to introduce the dystrophin gene, and exon skipping to produce partially functional dystrophin protein.

Q: Are there any side effects to increasing levels of utrophin protein?

Studies have shown that increasing levels of utrophin protein in muscles does not have any toxic effects. Utrophin plays a similar role to dystrophin and can compensate for its absence.

Q: How have stem cells been used in the treatment of MD?

Stem cells have shown promise in regenerating muscle in animal models. However, there are still challenges in applying stem cell therapy to MD patients, particularly in distributing the stem cells throughout the body.

Q: Is there hope for a cure for MD in the near future?

While there is no cure for MD yet, advancements in gene therapy, exon skipping, and other therapeutic approaches offer hope for improved treatment options that can enhance the quality of life for MD patients.

Summary & Key Takeaways

• Muscular dystrophy (MD) is a genetic disease that primarily affects boys, causing muscle weakness and degeneration.

• MD is the most common form of muscular dystrophy, affecting approximately 1 in 3,000 individuals.

• Current treatment options for MD are limited to supportive care, but recent advancements in gene therapy and exon skipping show promise for future therapeutic approaches.